These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 7870392

  • 1. Structural modifications of monoclonal antibodies following direct versus indirect labelling with 99Tcm: does fragmentation really occur?
    Behr T, Becker W, Hannappel E, Wolf F.
    Nucl Med Commun; 1994 Nov; 15(11):865-70. PubMed ID: 7870392
    [Abstract] [Full Text] [Related]

  • 2. Targeting of liver metastases of colorectal cancer with IgG, F(ab')2, and Fab' anti-carcinoembryonic antigen antibodies labeled with 99mTc: the role of metabolism and kinetics.
    Behr T, Becker W, Hannappel E, Goldenberg DM, Wolf F.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5777s-5785s. PubMed ID: 7493346
    [Abstract] [Full Text] [Related]

  • 3. In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments.
    Kinne RW, Schemer K, Behr T, Sharkey RM, Palombokinne E, Emmrich F, Goldenberg DM, Wolf F, Becker W.
    Nucl Med Commun; 1999 Jan 01; 20(1):67-75. PubMed ID: 9949415
    [Abstract] [Full Text] [Related]

  • 4. Production and characterization of anti-human IgG F(ab')2 antibody fragment.
    Valedkarimi Z, Nasiri H, Aghebati-Maleki L, Abdolalizadeh J, Esparvarinha M, Majidi J.
    Hum Antibodies; 2018 Jan 01; 26(4):171-176. PubMed ID: 29689714
    [Abstract] [Full Text] [Related]

  • 5. Radiochemical and radioimmunological data of 99Tcm-anti-CEA labelled by two diverse methods.
    Varvarigou AD, Archimandritis SC, Sekeri-Pataryas K, Sourlingas TG, Sivolapenko G, Paschali E.
    Nucl Med Commun; 1996 Jan 01; 17(1):80-8. PubMed ID: 8692479
    [Abstract] [Full Text] [Related]

  • 6. Labelling small quantities of monoclonal antibodies and their F(ab')2 fragments with technetium-99m.
    Tesic M, Sheldon KM, Ballinger JR, Boxen I.
    Nucl Med Biol; 1995 May 01; 22(4):451-7. PubMed ID: 7550021
    [Abstract] [Full Text] [Related]

  • 7. Structural perturbations of monoclonal antibodies following radiolabelling: in vitro evaluation of different techniques.
    John E, Wilder S, Thakur ML.
    Nucl Med Commun; 1994 Jan 01; 15(1):24-8. PubMed ID: 8152689
    [Abstract] [Full Text] [Related]

  • 8. Optimal conditions for the preparation of Fab and F(ab')2 fragments from monoclonal IgG of different rat IgG subclasses.
    Rousseaux J, Rousseaux-Prévost R, Bazin H.
    J Immunol Methods; 1983 Nov 11; 64(1-2):141-6. PubMed ID: 6644029
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Improved procedure for preparation of F(ab')2 fragments of mouse IgGs by papain digestion.
    Boguslawski SJ, Ledden DJ, Fredrickson RA.
    J Immunol Methods; 1989 Jun 02; 120(1):51-6. PubMed ID: 2732475
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Binding parameters and idiotypic profile of the whole immunoglobulin and Fab' fragments of murine monoclonal antibody to distinct determinants of the human high molecular weight-melanoma associated antigen.
    Temponi M, Gold AM, Ferrone S.
    Cancer Res; 1992 May 01; 52(9):2497-503. PubMed ID: 1373670
    [Abstract] [Full Text] [Related]

  • 14. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
    Cheung GL, Thomas TM, Rylatt DB.
    Protein Expr Purif; 2003 Nov 01; 32(1):135-40. PubMed ID: 14680950
    [Abstract] [Full Text] [Related]

  • 15. The stability of 99Tcm directly labelled to an Fab' antibody via stannous ion and mercaptoethanol reduction.
    Mardirossian G, Wu C, Rusckowski M, Hnatowich DJ.
    Nucl Med Commun; 1992 Jul 01; 13(7):503-12. PubMed ID: 1495677
    [Abstract] [Full Text] [Related]

  • 16. Preparation of F(ab')2 fragments from monoclonal mouse IgG1 suitable for use in radioimaging.
    Kurkela R, Vuolas L, Vihko P.
    J Immunol Methods; 1988 Jun 13; 110(2):229-36. PubMed ID: 3132507
    [Abstract] [Full Text] [Related]

  • 17. Anomalies in reduction-mediated technetium-99m labelling of monoclonal antibodies.
    Pimm MV, Rajput RS, Frier M, Gribben SJ.
    Eur J Nucl Med; 1991 Jun 13; 18(12):973-6. PubMed ID: 1778209
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Biodistribution of monoclonal IgG1, F(ab')2, and Fab' in mice after intravenous injection. Comparison between anti-B cell (anti-Lyb8.2) and irrelevant (MOPC-21) antibodies.
    Holton OD, Black CD, Parker RJ, Covell DG, Barbet J, Sieber SM, Talley MJ, Weinstein JN.
    J Immunol; 1987 Nov 01; 139(9):3041-9. PubMed ID: 3499463
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.